The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
Open accessAbstract
PurposeDiverse radionuclide imaging techniques are available for the diagnosis, staging, and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to detect and localise the disease, these imaging approaches variably characterise these tumours at the cellular and molecular levels and can guide therapy. Here we present updated guidelines jointly approved by the EANM and SNMMI for assisting nuclear medicine practitioners in not only the selection and performance of currently available single-photon emission computed tomography and positron emission tomography procedures, but also the interpretation and reporting of the results.MethodsGuidelines from related fields and relevant literature have been considered in consultation with leading experts involved in the management of PPGL. The provided information should be applied according to local laws and regulations as well as the availability of various radiopharmaceuticals.ConclusionSince the European Association of Nuclear Medicine 2012 guidelines, the excellent results obtained with gallium-68 (68Ga)-labelled somatostatin analogues (SSAs) in recent years have simplified the imaging approach for PPGL patients that can also be used for selecting patients for peptide receptor radionuclide therapy as a potential alternative or complement to the traditional theranostic approach with iodine-123 (123I)/iodine-131 (131I)-labelled meta-iodobenzylguanidine. Genomic characterisation of subgroups with differing risk of lesion development and subsequent metastatic spread is refining the use of molecular imaging in the personalised approach to hereditary PPGL patients for detection, staging, and follow-up surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303 · cited 2×
“In Europe, national guidelines may apply [135].”
BackgroundPheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · cited 1×
“5–14%) of all adrenal incidentalomas [3].”
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
(1991) · Annals of the ICRP · doi:10.1016/0146-6453(91)90017-b · Cited by 565
Hofman, M. S., Lau, W. F. E., & Hicks, R. J. (2015) · RadioGraphics · doi:10.1148/rg.352140164 · Cited by 561
Self-citationBiochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results
Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030005 · Cited by 492
Self-citationPasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Self-citationKrenning, E. P., Bakker, W., Kooij, P. P. M., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., & Kwekkeboom, D. J. (1992) · PubMed · Cited by 420
Mattsson, S., Johansson, L. F., Svegborn, S. L., Liniecki, J., Noßke, D., Riklund, K., Stabin, M. G., Taylor, D. M., Bolch, W. E., Carlsson, S., et al. (2015) · Annals of the ICRP · doi:10.1177/0146645314558019 · Cited by 405
(2008) · Annals of the ICRP · doi:10.1016/j.icrp.2008.08.003 · Cited by 390
Timmers, H. J. L. M., Chen, C. C., Carrasquillo, J. A., Whatley, M., Ling, A., Havekes, B., Eisenhofer, G., Martiniova, L., Adams, K. T., & Pacak, K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1248 · Cited by 348
Self-citationTimmers, H. J. L. M., Kozupa, A., Chen, C. C., Carrasquillo, J. A., Ling, A., Eisenhofer, G., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6297 · Cited by 340
Self-citationEisenhofer, G., Lenders, J. W. M., Siegert, G., Bornstein, S. R., Friberg, P., Milosevic, D., Mannelli, M., Linehan, W. M., Adams, K., Timmers, H. J., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.016 · Cited by 334
Self-citationPheochromocytomas: Detection with18F DOPA Whole-Body PET—Initial Results
Hoegerle, S., Nitzsche, E., Altehoefer, C., Ghanem, N., Manz, T., Brink, I., Reincke, M., Moser, E., & Neumann, H. P. H. (2002) · Radiology · doi:10.1148/radiol.2222010622 · Cited by 325
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Crona, J., Taïeb, D., & Pacak, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 324
Self-citationWild, D., Schmitt, J. S., Ginj, M., Mäcke, H. R., Bernard, B. F., Krenning, E., de Jong, M., Wenger, S., & Reubi, J.-C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1255-5 · Cited by 310
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging
Bombardieri, E., Giammarile, F., Aktolun, C., Baum, R. P., Bischof Delaloye, A., Maffioli, L., Moncayo, R., Mortelmans, L., Pepe, G., Reske, S. N., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1545-7 · Cited by 305
Timmers, H. J. L. M., Chen, C. C., Carrasquillo, J. A., Whatley, M., Ling, A., Eisenhofer, G., King, K. S., Rao, J. U., Wesley, R. A., Adams, K. T., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs188 · Cited by 283
Self-citationSOLANKP, K. K., BOMANJI, J., MOYES, J., MATHER, S. J., TRAINER, P. J., & BRITTON, K. E. (1992) · Nuclear Medicine Communications · doi:10.1097/00006231-199207000-00006 · Cited by 276
Janssen, I., Blanchet, E. M., Adams, K., Chen, C. C., Millo, C. M., Herscovitch, P., Taieb, D., Kebebew, E., Lehnert, H., Fojo, A. T., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2751 · Cited by 276
Self-citationSomatostatin receptor antagonists for imaging and therapy.
Fani, M., Nicolas, G. P., & Wild, D. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186783 · Cited by 274 · cited 2×
“According to the theranostic concept, (68)Ga-radiolabelled antagonists can also be used as theranostic agents [82].”
BackgroundWhole-Body18F Dopa PET for Detection of Gastrointestinal Carcinoid Tumors
Hoegerle, S., Altehoefer, C., Ghanem, N., Koehler, G., Waller, C. F., Scheruebl, H., Moser, E., & Nitzsche, E. (2001) · Radiology · doi:10.1148/radiology.220.2.r01au25373 · Cited by 269
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
Taïeb, D., Timmers, H. J., Hindié, E., Guillet, B. A., Neumann, H. P., Walz, M. K., Opocher, G., de Herder, W. W., Boedeker, C. C., de Krijger, R. R., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2215-8 · Cited by 256
Self-citation[123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1
van der Harst, E., de Herder, W. W., Bruining, H. A., Bonjer, H. J., de Krijger, R. R., Lamberts, S. W. J., van de Meiracker, A. H., Boomsma, F., Stijnen, T., Krenning, E. P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7238 · Cited by 253
Andrews, K. A., Ascher, D. B., Pires, D. E. V., Barnes, D. R., Vialard, L., Casey, R. T., Bradshaw, N., Adlard, J., Aylwin, S., Brennan, P., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105127 · Cited by 248
Ilias, I., Yu, J., Carrasquillo, J. A., Chen, C. C., Eisenhofer, G., Whatley, M., McElroy, B., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030235 · Cited by 241
Self-citationThe Warburg effect is genetically determined in inherited pheochromocytomas
Favier, J., Brière, J.-J., Burnichon, N., Rivière, J., Vescovo, L., Benit, P., Giscos-Douriez, I., De Reyniès, A., Bertherat, J., Badoual, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007094 · Cited by 232
Namavari, M., Bishop, A., Satyamurthy, N., Bida, G., & Barrio, J. R. (1992) · International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes · doi:10.1016/0883-2889(92)90217-3 · Cited by 223
Pacak, K., Eisenhofer, G., Carrasquillo, J. A., Chen, C. C., Li, S.-T., & Goldstein, D. S. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.6 · Cited by 216
Self-citationLópez-Jiménez, E., Gómez-López, G., Leandro-García, L. J., Muñoz, I., Schiavi, F., Montero-Conde, C., de Cubas, A. A., Ramires, R., Landa, I., Leskelä, S., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0256 · Cited by 209
Han, S., Suh, C. H., Woo, S., Kim, Y. J., & Lee, J. J. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.211706 · Cited by 205
Chang, C. A., Pattison, D. A., Tothill, R. W., Kong, G., Akhurst, T. J., Hicks, R. J., & Hofman, M. S. (2016) · Cancer Imaging · doi:10.1186/s40644-016-0084-2 · Cited by 198
Self-citationQuantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality
Bailey, D. L., & Willowson, K. P. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2542-4 · Cited by 196
Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4057 · Cited by 194
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Bombardieri, E., Ambrosini, V., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Del Vecchio, S., Maffioli, L., Mortelmans, L., Oyen, W., Pepe, G., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1473-6 · Cited by 193
Wild, D., Mäcke, H. R., Waser, B., Reubi, J. C., Ginj, M., Rasch, H., Müller-Brand, J., & Hofmann, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1697-4 · Cited by 192
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma
Eisenhofer, G., Pacak, K., Huynh, T.-T., Qin, N., Bratslavsky, G., Linehan, W. M., Mannelli, M., Friberg, P., Grebe, S. K., Timmers, H. J., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0211 · Cited by 189
Self-citationHescot, S., Curras-Freixes, M., Deutschbein, T., van Berkel, A., Vezzosi, D., Amar, L., de la Fouchardière, C., Valdes, N., Riccardi, F., Do Cao, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01968 · Cited by 188
Self-citationJanssen, I., Chen, C. C., Taieb, D., Patronas, N. J., Millo, C. M., Adams, K. T., Nambuba, J., Herscovitch, P., Sadowski, S. M., Fojo, A. T., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161018 · Cited by 187
Self-citationWhole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Fishbein, L., Khare, S., Wubbenhorst, B., DeSloover, D., D’Andrea, K., Merrill, S., Cho, N. W., Greenberg, R. A., Else, T., Montone, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7140 · Cited by 185
Pheochromocytoma: The Range of Appearances on Ultrasound, CT, MRI, and Functional Imaging
Leung, K., Stamm, M., Raja, A., & Low, G. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9126 · Cited by 177
Gabriel, M., Decristoforo, C., Donnemiller, E., Ulmer, H., Rychlinski, C. W., Mather, S. J., & Moncayo, R. (2003) · PubMed · Cited by 169
Ilias, Ι., Chen, C. C., Carrasquillo, J. A., Whatley, M. A., Ling, A. L., Lazúrová, I., Adams, K. T., Perera, S. M., & Pacák, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.052373 · Cited by 169
Guidelines on nuclear medicine imaging in neuroblastoma
Bar-Sever, Z., Biassoni, L., Shulkin, B., Kong, G., Hofman, M. S., Lopci, E., Manea, I., Koziorowski, J., Castellani, R., Boubaker, A., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4070-8 · Cited by 169
Fiebrich, H., Brouwers, A. H., Kerstens, M. N., Pijl, M. E. J., Kema, I. P., de Jong, J. R., Jager, P. L., Elsinga, P. H., Dierckx, R., van der Wal, J. E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1054 · Cited by 162
18F-DOPA positron emission tomography for the detection of glomus tumours
Hoegerle, S., Ghanem, N., Altehoefer, C., Schipper, J., Brink, I., Moser, E., & Neumann, H. P. H. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1115-3 · Cited by 162
Sandström, M., Velikyan, I., Garske-Román, U., Sörensen, J., Eriksson, B., Granberg, D., Lundqvist, H., Sundin, A., & Lubberink, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120600 · Cited by 161
Gimenez-Roqueplo, A.-P., Caumont-Prim, A., Houzard, C., Hignette, C., Hernigou, A., Halimi, P., Niccoli, P., Leboulleux, S., Amar, L., Borson-Chazot, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2975 · Cited by 159
Adverse Drug Reactions in Patients with Phaeochromocytoma: Incidence, Prevention and Management
Eisenhofer, G., Rivers, G., Rosas, A. L., Quezado, Z., Manger, W. M., & Pacák, K. (2007) · Drug Safety · doi:10.2165/00002018-200730110-00004 · Cited by 158
Pollard, P. J., El-Bahrawy, M. A., Poulsom, R., Elia, G., Killick, P., Kelly, G. P., Hunt, T., Jeffery, R. E., Seedhar, P., Barwell, J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0920 · Cited by 154
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.
Shulkin, B. L., Wieland, D. M., Schwaiger, M., et al. (1992) · PubMed · Cited by 153
Papathomas, T. G., Gaal, J., Corssmit, E. P. M., Oudijk, L., Korpershoek, E., Heimdal, K., Bayley, J., Morreau, H., van Dooren, M., Papaspyrou, K., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0623 · Cited by 147
Quantitative 177 Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
Beauregard, J., Hofman, M. S., Pereira, J. M., Eu, P., & Hicks, R. J. (2011) · Cancer Imaging · doi:10.1102/1470-7330.2011.0012 · Cited by 147
Self-citationTurková, H., Prodanov, T., Malý, M., Martucci, V. L., Adams, K. T., Widimsky, J., Jr., Chen, C. C., Ling, A. L., Kebebew, E., Stratakis, C. A., et al. (2015) · Endocrine Practice · doi:10.4158/ep15725.or · Cited by 147
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi, F. A., Shapiro, B., Fig, L. M., Mallette, S., & Sisson, J. C. (1989) · PubMed · Cited by 141
King, K. S., Chen, C. C., Alexopoulos, D. K., Whatley, M. A., Reynolds, J. C., Patronas, N. J., Ling, A. L., Adams, K. T., Xekouki, P., Lando, H. M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0333 · Cited by 141
Crona, J., Lamarca, Á., Ghosal, S., Welin, S., Skogseid, B. M., & Pacák, K. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0024 · Cited by 140
Tenenbaum, F., Lumbroso, J., Schlumberger, M. J., Mure, A., Plouin, P., Caillou, B., & Parmentier, C. (1995) · PubMed · Cited by 139
18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?
Taïeb, D., Sebag, F. A., Barlier, A., Tessonnier, L., Palazzo, F. F., Morange, I., Niccoli, P., Fakhry, N., Micco, C. D., Cammilleri, S., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060731 · Cited by 137
Self-citationFonte, J. S., Robles, J., Chen, C. C., Reynolds, J. C., Whatley, M. A., Ling, A. L., MERCADO-ASIS, L. B., Adams, K. T., Martucci, V. L., Fojo, T., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0243 · Cited by 137
Fottner, C., Helisch, A., Anlauf, M., Rossmann, H., Musholt, T., Kreft, A., Schadmand‐Fischer, S., Bartenstein, P., Lackner, K. J., Klöppel, G., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2352 · Cited by 137
Pandit-Taskar, N., Zanzonico, P., Staton, K. D., Carrasquillo, J. A., Reidy-Lagunes, D., Lyashchenko, S., Burnazi, E., Zhang, H., Lewis, J. S., Blasberg, R., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.193169 · Cited by 136
Self-citationArchier, A., Varoquaux, A. D., Garrigue, P., Montava, M., Guérin, C., Gabriel, S., Beschmout, E., Morange, I., Fakhry, N., Castinetti, F., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3268-2 · Cited by 132
Self-citationCT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma
Canu, L., Van Hemert, J. A. W., Kerstens, M. N., Hartman, R. P., Khanna, A., Kraljevic, I., Kastelan, D., Badiu, C., Ambroziak, U., Tabarin, A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01532 · Cited by 131 · cited 1×
“Typically, PPGLs show soft tissue attenuation that is greater than 10 Hounsfield units (HU) on CT [14].”
BackgroundSelf-citationBeheshti, M., Poecher, S., Vali, R., Waldenberger, P., Broinger, G., Nader, M., Kohlfürst, S., Pirich, C., Dralle, H., & Langsteger, W. (2009) · European Radiology · doi:10.1007/s00330-008-1280-7 · Cited by 127
Koopmans, K. P., Jager, P. L., Kema, I. P., Kerstens, M. N., Albers, F. W. J., & Dullaart, R. P. F. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047738 · Cited by 126
New imaging approaches to phaeochromocytomas and paragangliomas
Havekes, B., King, K. S., Lai, E. W., Romijn, J. A., Corssmit, E. P. M., & Pacák, K. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03648.x · Cited by 121
Remote, semiautomated production of 6-[18F]fluoro-l-dopa for human studies with PET
Luxen, A., Perlmutter, M. M., Bida, G. T., Moffaert, G. J. C. V., Cook, J. S., Satyamurthy, N., Phelps, M. E., & Barrio, J. R. (1990) · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · doi:10.1016/0883-2889(90)90191-i · Cited by 114
Timmers, H. J. L. M., Hadi, M., Carrasquillo, J. A., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042721 · Cited by 114
Self-citationFranzius, C., Hermann, K., Weckesser, M., et al. (2006) · PubMed · Cited by 105
Remote, semiautomated production of 6‐[F‐18]fluoro‐L‐DOPA for human studies with PET
Luxen, A., Barrio, J. R., Moffaert, G. J. C. V., Perlmutter, M. M., Cook, J., & Phelps, M. E. (1989) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.25802601199 · Cited by 99
68Ga-DOTA-TATE PET vs. 123I-MIBG in Identifying Malignant Neural Crest Tumours
Naji, M., Zhao, C., Welsh, S. J., Meades, R., Win, Z., Ferrarese, A., Tan, T., Rubello, D., & AL-NAHHAS, A. M. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0396-8 · Cited by 98
Self-citationKauhanen, S. P., Seppänen, M., Ovaska, J. T., Minn, H. R. I., Bergman, J. R., Korsoff, P., Salmela, P. I., Saltevo, J. T., Sane, T., Välimäki, M. J., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0229 · Cited by 97
Jha, A., Ling, A. L., Millo, C., Gupta, G., Viana, B., Lin, F. I., Herscovitch, P., Adams, K. T., Taïeb, D., Metwalli, A. R., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3896-9 · Cited by 97
Self-citationJacobson, A. F., & Travin, M. I. (2015) · Journal of Nuclear Cardiology · doi:10.1007/s12350-015-0170-z · Cited by 92
18 F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
Imani, F., Agopian, V. G., Auerbach, M. S., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058396 · Cited by 92
Modern Nuclear Imaging for Paragangliomas: Beyond SPECT
Taïeb, D., Neumann, H. P. H., Rubello, D., AL-NAHHAS, A. M., Guillet, B. A., & Hindié, E. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098152 · Cited by 90
Self-citationPheochromocytomas: Detection with11C Hydroxyephedrine PET
Trampal, C., Engler, H., Juhlin, C., et al. (2004) · Radiology · doi:10.1148/radiol.2302021678 · Cited by 90
Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
Därr, R., Nambuba, J., Rivero, J. D., Janssen, I., Merino, M. J., Todorović, M., Balint, B., Jochmanová, I., Prchal, J. T., Lechan, R. M., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0231 · Cited by 87
Self-citationEvaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
Fanti, S., Ambrosini, V., Tomassetti, P., Castellucci, P., Montini, G. C., Allegri, V., Grassetto, G., Rubello, D., Nanni, C., & Franchi, R. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.010 · Cited by 83
Self-citationTaïeb, D., Tessonnier, L., Sebag, F. A., Niccoli, P., Morange, I., Colavolpe, C., Micco, C. D., Barlier, A., Palazzo, F. F., Henry, J. F., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03257.x · Cited by 82
Self-citationTimmers, H. J. L. M., Eisenhofer, G., Carrasquillo, J. A., Chen, C. C., Whatley, M. A., Ling, A. L., Adams, K. T., & Pacák, K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03496.x · Cited by 81
Self-citationOctreotide Scintigraphy for the Detection of Paragangliomas
Telischi, F. F., Bustillo, A., Whiteman, M. L. H., et al. (2000) · Otolaryngology · doi:10.1016/s0194-5998(00)70048-9 · Cited by 80
Mann, G. N., Link, J. M., Pham, P., Pickett, C. A., Byrd, D. R., Kinahan, P. E., Krohn, K. A., & Mankoff, D. A. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.04.022 · Cited by 79
Guérin, C., Pattou, F. N., Brunaud, L., Lifante, J., Mirallié, É., Haissaguerre, M., Huglo, D. G., Olivier, P., Houzard, C., Ansquer, C., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00254 · Cited by 78
Self-citationCherk, M. H., Kong, G., Hicks, R. J., & Hofman, M. S. (2018) · Cancer Imaging · doi:10.1186/s40644-018-0136-x · Cited by 78
Self-citationVernaleken, I., Kumakura, Y., Cumming, P. D., Buchholz, H., Siessmeier, T., Stoeter, P., Müller, M. J., Bartenstein, P., & Gründer, G. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.11.014 · Cited by 76
Jafri, M., Whitworth, J., Rattenberry, E., Vialard, L., Kilby, G., Kumar, A., Izatt, L., Lalloo, F. I., Brennan, P., Cook, J. A., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12074 · Cited by 76
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers
Rijken, J. A., Niemeijer, N. D., Jonker, M. A., Eijkelenkamp, K., Jansen, J. C., van Berkel, A., Timmers, H. J. L. M., Kunst, H. P. M., Bisschop, P. H. L. T., Kerstens, M. N., et al. (2017) · Clinical Genetics · doi:10.1111/cge.13055 · Cited by 72
Self-citationKaltsas, G., Mukherjee, J. J., & Grossman, A. B. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s47 · Cited by 70
Are we overestimating the penetrance of mutations in SDHB?
Schiavi, F., Milne, R. L., Anda, E., Blay, P., Castellano, M., Opocher, G., Robledo, M., & Cascón, A. (2010) · Human Mutation · doi:10.1002/humu.21269 · Cited by 67
Lasnon, C., Hicks, R. J., Beauregard, J., Milner, A. D., Paciencia, M., Guizard, A., Bardet, S., Gervais, R., Lemoel, G., Zalcman, G., et al. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318251e3d1 · Cited by 65
Self-citationLuster, M., Karges, W., Zeich, K., Pauls, S., Verburg, F. A., Dralle, H., Glatting, G., Buck, A. K., Solbach, C., Neumaier, B., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1294-7 · Cited by 64
Metastatic pheochromocytoma: Does the size and age matter?
Zelinka, T., Musil, Z., Duskova, J., Burton, D., Merino, M. J., Milosevic, D., Widimsky, J., Jr., & Pacák, K. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02518.x · Cited by 63
Duet, M., Sauvaget, E., Pételle, B., Rizzo, N., Guichard, J., Wassef, M., Cloirec, J. L., Herman, P., & Huy, P. T. B. (2003) · PubMed · Cited by 63
MUROS, M. A., Elvira, J. M. L., Rodriguez, A. C., et al. (1998) · Nuclear Medicine Communications · doi:10.1097/00006231-199808000-00003 · Cited by 58
Absorbed 18F-FDG Dose to the Fetus During Early Pregnancy: FIGURE 1.
Zanotti‐Fregonara, P., Jan, S., Taïeb, D., Cammilleri, S., Trébossen, R., Hindié, E., & MUNDLER, O. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.071878 · Cited by 57
Self-citationRufini, V., Treglia, G., Castaldi, P., Perotti, G., Calcagni, M. L., Corsello, S. M., Galli, G., Fanti, S., & Giordano, A. (2011) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328345a340 · Cited by 57
Self-citationPenetrance and clinical consequences of a gross SDHB deletion in a large family
Solis, D. C., Burnichon, N., Timmers, H., Raygada, M. J., Kozupa, A., Merino, M. J., Makey, D., Adams, K. T., Vénisse, A., Gimenez‐Roqueplo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01157.x · Cited by 57
Self-citationAalbersberg, E. A., der Veen, B. J. D. W., Versleijen, M. W. J., Saveur, L. J., Valk, G. D., Tesselaar, M. E. T., & Stokkel, M. P. M. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4117-x · Cited by 56
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family
Hes, F. J., Weiss, M. M., Woortman, S. A., de Miranda, N. F. C. C., van Bunderen, P. A., Bonsing, B. A., Stokkel, M. P. M., Morreau, H., Romijn, J. A., Jansen, J. C., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-92 · Cited by 55
68Ga-labelled peptides in the management of neuroectodermal tumours
Naji, M., & AL-NAHHAS, A. M. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1990-y · Cited by 54
Role of DOTATATE ‐ PET / CT in preoperative assessment of phaeochromocytoma and paragangliomas
Gild, M. L., Naik, N., Hoang, J., Hsiao, E., McGrath, R. T., Sywak, M. S., Sidhu, S. B., Delbridge, L., Robinson, B. G., Schembri, G. P., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13737 · Cited by 54
Kan, Y., Zhang, S., Wang, W., Liu, J., Yang, J., & Wang, Z. (2018) · Acta Radiologica · doi:10.1177/0284185118764206 · Cited by 52
Martiniova, L., Perera, S. M., Brouwers, F. M., Alesci, S., Abu-Asab, M. S., Marvelle, A. F., Kiesewetter, D. O., Thomasson, D. M., Morris, J. C., Květňanský, R., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0090 · Cited by 50
18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma
Taïeb, D., Jha, A., Guérin, C., Pang, Y. K., Adams, K. T., Chen, C. C., Romanet, P., Roche, P., Essamet, W., Ling, A. L., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02324 · Cited by 50
Self-citationFunctional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
Janssen, I., Chen, C. C., Zhuang, Z., Millo, C., Wolf, K. I., Ling, A. L., Lin, F. I., Adams, K. T., Herscovitch, P., Feelders, R. A., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187690 · Cited by 48
Self-citationSpan, P. N., Rao, J. U., Ophuis, S. B. J. O., Lenders, J. W. M., Sweep, F. C. G. J., Wesseling, P., Küsters, B., van Nederveen, F. H., de Krijger, R. R., Hermus, A. R. M. M., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0184 · Cited by 47
Self-citationPatient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors
Grimes, J., Celler, A. M., Birkenfeld, B., Shcherbinin, S., Listewnik, M. H., Piwowarska-Bilska, H., Mikołajczak, R., & Zorga, P. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088203 · Cited by 43
Casey, R. T., Warren, A. Y., Martín, J., Challis, B., Rattenberry, E., Whitworth, J., Andrews, K. A., Roberts, T., Clark, G. R., West, H. D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00562 · Cited by 43
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
Taïeb, D., & Pacák, K. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.08.001 · Cited by 43
Self-citationDaniel, E., Jones, R. N., Bull, M., & Newell-Price, J. D. C. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0595 · Cited by 37
Kong, G., Schenberg, T., Yates, C. J., Trainer, A. H., Sachithanandan, N., Iravani, A., Kumar, A. S. R., Hofman, M. S., Akhurst, T. J., Michael, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00018 · Cited by 36
Self-citationThe Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG–Based Study
Garrigue, P., Bodin-Hullin, A., Balasse, L., Fernandez-Sauze, S., Essamet, W., Dignat‐George, F., Pacák, K., Guillet, B. A., & Taïeb, D. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192674 · Cited by 33
Self-citationModern PET imaging for paragangliomas: Relation to genetic mutations
Taïeb, D., Rubello, D., AL-NAHHAS, A. M., Calzada-Nocaudie, M., Marzola, M. C., & Hindié, E. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.05.004 · Cited by 22
Self-citationGenetic status determines 18F‐ FDG uptake in pheochromocytoma/paraganglioma
Tiwari, A., Shah, N. S., Sarathi, V., Malhotra, G., Bakshi, G., Prakash, G. J., Khadilkar, K. S., Pandit, R., Lila, A. R., & Bandgar, T. (2017) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12620 · Cited by 20
Heesterman, B. L., de Pont, L. M. H., van der Mey, A. G. L., Bayley, J., Corssmit, E. P. M., Hes, F. J., Verbist, B. M., van Benthem, P. P. G., & Jansen, J. C. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0116-4 · Cited by 17
Nambuba, J., Därr, R., Janssen, I., Bullova, P., Adams, K. T., Millo, C., Bourdeau, I., Kassai, A., Yang, C., Kebebew, E., et al. (2015) · AACE Clinical Case Reports · doi:10.4158/ep15759.cr · Cited by 14
Cited by
Personalized Management of Pheochromocytoma and Paraganglioma
Nölting, S., Bechmann, N., Taieb, D., Beuschlein, F., Fassnacht, M., Kroiss, M., Eisenhofer, G., Grossman, A., & Pacak, K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab019 · Cited by 417
Self-citationLenders, J. W. M., Kerstens, M. N., Amar, L., Prejbisz, A., Robledo, M., Taieb, D., Pacak, K., Crona, J., Zelinka, T., Mannelli, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002438 · Cited by 413
Self-citationNuclear medicine and molecular imaging advances in the 21st century
Vaz, S. C., Oliveira, F., Herrmann, K., & Veit-Haibach, P. (2020) · The British Journal of Radiology · doi:10.1259/bjr.20200095 · Cited by 86
Metadata
- Authors
- Taïeb, D., Hicks, R. J., Hindié, E., Guillet, B. A., Avram, A., Ghedini, P., Timmers, H. J., Scott, A. T., Elojeimy, S., Rubello, D., Virgolini, I. J., Fanti, S., Balogova, S., Pandit-Taskar, N., & Pacak, K.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2019-06-29
- Volume
- 46
- Issue
- 10
- Pages
- 2112-2137
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2954992995
- Cited by
- 403
- References
- 120
- FWCI
- 35.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.